Cargando…
mPEG-PLGA Nanoparticles Labelled with Loaded or Conjugated Rhodamine-B for Potential Nose-to-Brain Delivery
Nowdays, neurodegenerative diseases represent a great challenge from both the therapeutic and diagnostic points of view. Indeed, several physiological barriers of the body, including the blood brain barrier (BBB), nasal, dermal, and intestinal barriers, interpose between the development of new drugs...
Autores principales: | Craparo, Emanuela Fabiola, Musumeci, Teresa, Bonaccorso, Angela, Pellitteri, Rosalia, Romeo, Alessia, Naletova, Irina, Cucci, Lorena Maria, Cavallaro, Gennara, Satriano, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471208/ https://www.ncbi.nlm.nih.gov/pubmed/34575584 http://dx.doi.org/10.3390/pharmaceutics13091508 |
Ejemplares similares
-
Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content
por: Li, Mingguang, et al.
Publicado: (2012) -
Tetracycline-grafted mPEG-PLGA micelles for bone-targeting and osteoporotic improvement
por: Que, Yunduan, et al.
Publicado: (2022) -
Development of New Targeted Inulin Complex Nanoaggregates for siRNA Delivery in Antitumor Therapy
por: Cavallaro, Gennara, et al.
Publicado: (2021) -
Rapamycin-Loaded Polymeric Nanoparticles as an Advanced Formulation for Macrophage Targeting in Atherosclerosis
por: Craparo, Emanuela Fabiola, et al.
Publicado: (2021) -
Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer
por: Cheng, Lihua, et al.
Publicado: (2011)